People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with ...

The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...

The ‘Black, Black History Month’ Pop-Up Museum sits in Old Town one of the earliest Black communities in Portland, using art, history, and music to celebrate the past and present and set a ...

Ketamine-assisted therapy lifted me out of depression. But it remains costly — and controversial Health Canada approved a prescription esketamine nasal spray called Spravato in 2020 to help ...

FDA approves esketamine nasal spray as a standalone treatment for adults with treatment-resistant depression, offering rapid ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

An estimated 21 million American adults suffer from clinical depression. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...